Planta Med 2023; 89(08): 790-799
DOI: 10.1055/a-1828-2479
Biological and Pharmacological Activity
Original Papers

In Vitro and In Silico Evaluation of ACE2 and LOX Inhibitory Activity of Origanum Essential Oils and Carvacrol[ # ]

1   Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey
2   Faculty of Pharmacy, Eastern Mediterranean University, Famagusta, N. Cyprus, Mersin 10, Turkey
,
3   Department of Medical Biochemistry, Faculty of Medicine, Girne American University, Kyrenia, Mersin 10, Turkey
,
4   Department of Pharmacognosy, School of Pharmacy, Istanbul Medipol University, Beykoz, Istanbul, Turkey
5   Graduate School of Health Sciences, Anadolu University, Eskişehir, Turkey
,
6   Department of Pharmaceutical Microbiology, School of Pharmacy, Istanbul Medipol University, Beykoz, Istanbul, Turkey
7   Institute of Sciences, Istanbul University, Istanbul, Turkey
,
2   Faculty of Pharmacy, Eastern Mediterranean University, Famagusta, N. Cyprus, Mersin 10, Turkey
,
1   Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey
,
2   Faculty of Pharmacy, Eastern Mediterranean University, Famagusta, N. Cyprus, Mersin 10, Turkey
,
8   Department of Pharmacognosy, Faculty of Pharmacy, Near East University, Nicosia, N. Cyprus, Mersin 10, Turkey
› Institutsangaben
Gefördert durch: Anadolu University Scientific Research Projects Commission BAP 2005S058
Zoom Image

Abstract

Origanum spp. are used both for culinary purposes and for their biological activities. In this study, commercial Origanum majorana, Origanum minutiflorum, Origanum vulgare, and Origanum onites essential oils and their prominent constituent carvacrol were evaluated for their in vitro and in silico angiotensin-converting enzyme 2 and lipoxygenase enzyme inhibitory potentials. The essential oils were analysed by gas chromatography-flame ionisation detection and gas chromatography-mass spectrometry, where carvacrol was identified as the major component (62 – 81%), confirming the quality. In vitro enzyme inhibition assays were conducted both with the essential oils (20 µg/mL) and with carvacrol (5 µg/mL). The comparative values of angiotensin-converting enzyme 2 percent inhibition for O. majorana, O. minutiflorum, O. vulgare, and O. onites essential oils were determined as 85.5, 79.1, 74.3, and 42.8%, respectively. As a result of the enzyme assays, carvacrol showed 90.7% in vitro angiotensin-converting enzyme 2 inhibitory activity. The in vitro lipoxygenase inhibition of the essential oils (in the same order) was 89.4, 78.9, 81.1, and 73.5%, respectively, where carvacrol showed 74.8% inhibition. In addition, protein–ligand docking and interaction profiling was used to gain structural and mechanistic insights into the angiotensin-converting enzyme 2 and lipoxygenase inhibitory potentials of major Origanum essential oil constituents. The in silico findings agreed with the significant enzyme inhibition activity observed in vitro. Further in vivo studies are suggested to confirm the safety and efficacy of the oils.

# Dedicated to Professor Dr. Gerhard Franz on the occasion of his 85th birthday.


Supporting Information



Publikationsverlauf

Eingereicht: 01. Dezember 2021

Angenommen nach Revision: 08. April 2022

Accepted Manuscript online:
19. April 2022

Artikel online veröffentlicht:
28. September 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany